Literature DB >> 2222189

HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea.

R C Sanders1, A Levin, G Anian, I Webber, H Lee, P Swanson, A Diwan, R Desowitz, W A Blattner, M P Alpers.   

Abstract

Serum samples collected in 1984 during a malariometric survey of two villages in the East Sepik Province of Papua New Guinea were tested for antibodies to HTLV-I. None of the villagers showed any symptoms suggestive of retrovirus infection. Eighteen of the 186 (9.5%) sera tested at that time were found to be positive. Blood samples were subsequently obtained from fifteen of the eighteen positives and subjected to analysis by enzyme-linked immunosorbent assay (ELISA), radioimmuno assay (RIA), radioimmunoprecipitation assay (RIPA), and Western blot (WB). Fourteen of the fifteen gave a positive ELISA response, but none were unequivocally positive by p 24 RIA. All sera tested were reactive to gag antigens by WB, but gave "indeterminate" results currently accepted criteria. Notably absent from the WB profiles of all of the study subjects was an antibody response to HTLV-I envelope protein gp 46. It is possible that these antibody responses are directed against a variant of HTLV-I or to a novel retrovirus which possesses core antigens similar to those of HTLV-I but has different envelope antigens. Until a virus is isolated, or the viral genome is identified in infected lymphocytes, the possibility remains that the response may be due to factors unrelated to retrovirus infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222189     DOI: 10.1007/bf01311009

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  HTLV-1 myeloneuropathy in the Solomon Islands.

Authors:  A Ajdukiewicz; R Yanagihara; R M Garruto; D C Gajdusek; S S Alexander
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

2.  HTLV-I antibodies in Papua New Guinea.

Authors:  B Currie; Y Hinuma; J Imai; S Cumming; R Doherty
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

3.  Antibodies to HTLV-I in populations of the southwestern Pacific.

Authors:  D M Asher; J Goudsmit; K L Pomeroy; R M Garruto; M Bakker; S G Ono; N Elliot; K Harris; H Askins; Z Eldadah
Journal:  J Med Virol       Date:  1988-12       Impact factor: 2.327

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans.

Authors:  R J Biggar; P L Gigase; M Melbye; L Kestens; P S Sarin; A J Bodner; P Demedts; W J Stevens; L Paluku; C Delacollette
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

6.  Enzyme-linked immunosorbent assay of antibodies to adult T-cell leukemia-associated antigens.

Authors:  H Taguchi; T Sawada; M Fujishita; T Morimoto; K Niiya; I Miyoshi
Journal:  Gan       Date:  1983-04

7.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

8.  HTLV-1 infection in Papua New Guinea: evidence for serologic false positivity.

Authors:  J N Weber; N Banatvala; S Clayden; K P McAdam; S Palmer; H Moulsdale; J Tosswill; P Dilger; R Thorpe; S Amann
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

9.  Expression of HTLV-specific polypeptides in various human T-cell lines.

Authors:  Y Koyanagi; Y Hinuma; J Schneider; T Chosa; G Hunsmann; N Kobayashi; M Hatanaka; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

10.  HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey.

Authors:  R J Brindle; R P Eglin; A J Parsons; A V Hill; J B Selkon
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

View more
  4 in total

1.  The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea.

Authors:  R C Sanders; P M Wai'in; S S Alexander; A G Levin; W A Blattner; M P Alpers
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

Authors:  R Mahieux; P Horal; P Mauclère; O Mercereau-Puijalon; M Guillotte; L Meertens; E Murphy; A Gessain
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea.

Authors:  R Yanagihara; V R Nerurkar; R M Garruto; M A Miller; M E Leon-Monzon; C L Jenkins; R C Sanders; P P Liberski; M P Alpers; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

4.  Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification.

Authors:  R Yanagihara; A B Ajdukiewicz; V R Nerurkar; R M Garruto; D C Gajdusek
Journal:  Jpn J Cancer Res       Date:  1991-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.